About this trial
This study to collect the real-world clinical outcome data of EkoSonicTM Endovascular System in Chinese patients with acute pulmonary embolism during practical clinical care.
Eligibility criteria
Qualifiers
The patients with acute symptomatic pulmonary embolism (Symptomatic duration < 14 days).
The right ventricle diameter to left ventricle diameter of end-diastolic dimension ratio ≥1 measured by echocardiographic image
Investigator has selected the EkoSonicTM Endovascular System with r-tPA to treat patient.
Disqualifiers
The patients with acute symptomatic pulmonary embolism (Symptomatic duration < 14 days).
The right ventricle diameter to left ventricle diameter of end-diastolic dimension ratio ≥1 measured by echocardiographic image
Investigator has selected the EkoSonicTM Endovascular System with r-tPA to treat patient.
Trial design
Treatments tested in this trial
- EkoSonicTM Endovascular System